DARPA AWARDS UP TO $1.1 M FOR CLINICAL DEVICE DEVELOPMENT

DARPA AWARDS MODULAR BIONICS UP TO $1.1 M FOR ADDITIONAL CLINICAL DEVICE DEVELOPMENT
May 2022 - The Defense Advanced Research Projects Agency (DARPA) has awarded additional contract items worth up to $1.1M to Modular Bionics Inc. to advance development of the Clinical Link Interface for Neural Communication (C-LINC™), a wireless clinical platform.

DARPA’s Biological Technologies Office (BTO) awarded the contract.

NOT FOR HUMAN USE - these products are not FDA approved for human use.

Approved for Public Release, Distribution Unlimited

The research reported in this document/presentation was performed in connection with contract/purchase order number W911NF-17-C-0057 with the U.S. Army Contracting Command - Aberdeen Proving Grounds (ACC-APG) and the Defense Advanced Research Projects Agency (DARPA). The views and conclusions contained in this document/presentation are those of the authors and should not be interpreted as presenting the official policies or position, either expressed or implied, of ACC-APG, DARPA, or the U.S. Government unless so designated by other authorized documents. Citation of manufacturer’s or trade names does not constitute an official endorsement or approval of the use thereof. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation hereon.